Shui-Xian Du

468 citations
12 papers · 328 indexed · h-index 8
Topics
Liver Disease Diagnosis and Treatment (11 papers)Lipid metabolism and disorders (3 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)
Partner nations
China

In The Last Decade

Shui-Xian Du

11 papers receiving 319 citations

Peers

Shui-Xian Du
Comparison fields: 5 of 40
  • Epidemiology 301
  • Hepatology 142
  • Endocrinology, Diabetes and Metabolism 106
  • Cardiology and Cardiovascular Medicine 42
  • Surgery 40
Replace Scarlett Lopez with:
Scarlett Lopez United States
Claudia La Mantia Italy
Helene Gellert‐Kristensen Denmark
Wanqing Liu United States
Alex Zimmet United States
Koichiro Kusumoto Japan
Noriko Oza Japan
Hossein Nobakht Iran
Abbey Barnard United States
Maria Rosa Barcellona Italy
Shui-Xian Du relative to Scarlett Lopez United States Scarlett Lopez's profile →
Citations per field
00.5×1.5×2.4×
Scarlett Lopez · 1×
Citations per year

Countries citing papers authored by Shui-Xian Du

Since Specialization
Citations

This map shows the geographic impact of Shui-Xian Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shui-Xian Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shui-Xian Du more than expected).

Fields of papers citing papers by Shui-Xian Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shui-Xian Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shui-Xian Du. The network helps show where Shui-Xian Du may publish in the future.

Co-authorship network of co-authors of Shui-Xian Du

This figure shows the co-authorship network connecting the top 25 collaborators of Shui-Xian Du. A scholar is included among the top collaborators of Shui-Xian Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shui-Xian Du. Shui-Xian Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 6
2 54
3 0
4 1
5 4
6 17
7 26
8 178
9 7
10 8
11 15
12 12

About Shui-Xian Du

Shui-Xian Du is a scholar working on Hepatology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 328 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Lipid metabolism and disorders (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (142 citations), Epidemiology (301 citations) and Endocrinology, Diabetes and Metabolism (106 citations). Shui-Xian Du has collaborated with scholars based in China. Frequent co-authors include Yongning Xin, Shousheng Liu, Quanjiang Dong, Qing Zhang, Shiying Xuan, Mengzhen Dong, Jie Zhang, Jie Zhao, Xuefeng Ma and Zhenzhen Zhao. Their work appears in journals such as Oncotarget, European Radiology and Lipids in Health and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026